HL151

· Hanlim Pharm. Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HL151, covering 2018-08-28 to 2018-08-31. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients [Phase 3]